Synergistic effects of common schizophrenia risk variants N Schrode, SM Ho, K Yamamuro, A Dobbyn, L Huckins, MR Matos, ... Nature genetics 51 (10), 1475-1485, 2019 | 232 | 2019 |
Neuronal impact of patient-specific aberrant NRXN1α splicing E Flaherty, S Zhu, N Barretto, E Cheng, PJM Deans, MB Fernando, ... Nature genetics 51 (12), 1679-1690, 2019 | 121 | 2019 |
Psychosis risk candidate ZNF804A localizes to synapses and regulates neurite formation and dendritic spine structure PJM Deans, P Raval, KJ Sellers, NJF Gatford, S Halai, RRR Duarte, ... Biological psychiatry 82 (1), 49-61, 2017 | 102 | 2017 |
Common genetic variation in humans impacts in vitro susceptibility to SARS-CoV-2 infection K Dobrindt, DA Hoagland, C Seah, B Kassim, CP O'Shea, A Murphy, ... Stem cell reports 16 (3), 505-518, 2021 | 62 | 2021 |
Modeling gene× environment interactions in PTSD using human neurons reveals diagnosis-specific glucocorticoid-induced gene expression C Seah, MS Breen, T Rusielewicz, HN Bader, C Xu, CJ Hunter, ... Nature neuroscience 25 (11), 1434-1445, 2022 | 41 | 2022 |
Characterisation of neurons derived from a cortical human neural stem cell line CTX0E16 GW Anderson, PJM Deans, RDT Taylor, P Raval, D Chen, H Lowder, ... Stem cell research & therapy 6, 1-20, 2015 | 24 | 2015 |
Applying stem cells and CRISPR engineering to uncover the etiology of schizophrenia PJM Deans, KJ Brennand Current opinion in neurobiology 69, 193-201, 2021 | 23 | 2021 |
Using the dCas9-KRAB system to repress gene expression in hiPSC-derived NGN2 neurons A Li, S Cartwright, A Yu, SM Ho, N Schrode, PJM Deans, MR Matos, ... STAR protocols 2 (2), 100580, 2021 | 11 | 2021 |
Analysis framework and experimental design for evaluating synergy-driving gene expression N Schrode, C Seah, PJM Deans, G Hoffman, KJ Brennand Nature protocols 16 (2), 812-840, 2021 | 11 | 2021 |
Convergent impact of schizophrenia risk genes KG Townsley, A Li, PM Deans, JF Fullard, A Yu, S Cartwright, W Zhang, ... | 9 | 2022 |
Attenuated transcriptional response to pro-inflammatory cytokines in schizophrenia hiPSC-derived neural progenitor cells A Bhat, H Irizar, ACM Couch, P Raval, RRR Duarte, LD Polit, B Hanger, ... Brain, Behavior, and Immunity 105, 82-97, 2022 | 8 | 2022 |
Neuroligin-3 and neuroligin-4X form nanoscopic clusters and regulate growth cone organization and size NJF Gatford, PJM Deans, RRR Duarte, G Chennell, KJ Sellers, P Raval, ... Human Molecular Genetics 31 (5), 674-691, 2022 | 8 | 2022 |
Precise Therapeutic Targeting of Distinct NRXN1+/− Mutations MB Fernando, Y Fan, Y Zhang, S Kammourh, AN Murphy, S Ghorbani, ... bioRxiv, 2023.10. 28.564543, 2023 | 5* | 2023 |
Non-additive effects of schizophrenia risk genes reflect convergent downstream function PJM Deans, C Seah, J Johnson, JG Gonzalez, K Townsley, E Cao, ... medRxiv, 2023 | 5 | 2023 |
Dynamic stress-and inflammatory-based regulation of psychiatric risk loci in human neurons KG Retallick-Townsley, S Lee, S Cartwright, S Cohen, A Sen, M Jia, ... bioRxiv, 2024 | 3 | 2024 |
Nanoscopic Clustering of Neuroligin-3 and Neuroligin-4X Regulates Growth Cone Organization and Size NJF Gatford, PJ Michael Deans, RRR Duarte, G Chennell, P Raval, ... bioRxiv, 546499, 2019 | 2 | 2019 |
O10. 7. Investigating the mechanisms underlying the beneficial effects of estrogens in schizophrenia PJ Michael Deans, C Shum, L Perfect, M Conforti, R Duarte, ... Schizophrenia Bulletin 44 (suppl_1), S105-S105, 2018 | 2 | 2018 |
Better together: Non-additive interactions between schizophrenia risk genes PJM Deans, KJ Brennand Cell Genomics 3 (9), 2023 | 1 | 2023 |
Schizophrenia risk mapping and functional engineering of the 3D genome in three neuronal subtypes SK Powell, W Liao, C O’Shea, S Kammourh, S Ghorbani, R Rigat, R Elahi, ... bioRxiv, 2023 | 1 | 2023 |
Author Correction: Modeling gene× environment interactions in PTSD using human neurons reveals diagnosis-specific glucocorticoid-induced gene expression C Seah, MS Breen, T Rusielewicz, HN Bader, C Xu, CJ Hunter, ... Nature Neuroscience 28 (1), 214, 2024 | | 2024 |